Loading...
Paclitaxel Suppresses Hepatocellular Carcinoma Tumorigenesis Through Regulating Circ-BIRC6/miR-877-5p/YWHAZ Axis
BACKGROUND: Paclitaxel is an effective chemotherapeutic agent for the treatment of cancer patients. Accumulating evidence suggests that circular RNAs (circRNAs) play critical roles in the occurrence and development of human cancers. However, there are few studies on interactions between paclitaxel a...
Saved in:
| Published in: | Onco Targets Ther |
|---|---|
| Main Authors: | , , , , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Dove
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7519811/ https://ncbi.nlm.nih.gov/pubmed/33061425 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S261700 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|